-
Atorvastatin Workflows for Metabolic Research
2026-09-15
Atorvastatin supports controlled studies of cholesterol metabolism, vascular phenotypes, and emerging ferroptosis biology. This practical guide connects concentration selection, assay design, formulation, and troubleshooting with findings from a recent hepatocellular carcinoma study.
-
Annexin V-APC/7-AAD Apoptosis Kit Workflow
2026-09-15
Build a rapid, dual-parameter workflow for separating viable, apoptotic, and necrotic cells in cancer and immune-cell experiments. The assay combines cell-surface phosphatidylserine exposure with membrane-integrity readout, making it especially useful for mechanism-focused studies such as the PSA-CD56/Siglec-7 immune-evasion model.
-
Cefodizime Workflows for Antibacterial Research
2026-09-14
Build reproducible Cefodizime assays around PBP-directed killing, matrix-aware MIC testing, and carefully selected susceptible and resistant controls. The workflow also separates direct antibacterial effects from the compound’s reported immunomodulatory activity, helping researchers interpret respiratory, urinary, and host-response models more rigorously.
-
Isoproterenol Sulfate Dihydrate: Assay Guide
2026-09-14
This scenario-based guide explains how Isoproterenol sulfate dihydrate (SKU C6402) can support controlled beta-adrenergic receptor signaling studies alongside cell viability, proliferation, and cytotoxicity assays. It covers assay compatibility, solution preparation, data interpretation, storage, and practical vendor-selection criteria.
-
WEHI-539 and the Logic of BCL-XL Dependency
2026-09-13
A translational framework for using WEHI-539 to distinguish BCL-XL-dependent apoptosis from broader stress responses, with implications for cancer stem cell sensitization, chemoresistance, and rational experimental design.
-
Acetoacetic Acid Sodium Salt in Metabolic Assays
2026-09-12
Acetoacetic acid sodium salt provides a water-compatible way to model ketone-body exposure, build matrix-spike controls, and investigate fatty acid catabolism. This workflow-focused guide covers dosing design, LC-MS assay preparation, controls, and troubleshooting for reproducible energy metabolism research.
-
BGJ398 Workflows for FGFR Signaling Research
2026-09-12
BGJ398 (NVP-BGJ398) enables selective interrogation of FGFR1/2/3 signaling in cancer models, while its pathway-focused profile also supports carefully controlled developmental assays. This guide translates the compound’s biochemical selectivity into practical dosing, readout, troubleshooting, and cross-model validation strategies.
-
Arrb2–6-ketoLCA Axis in Liver IRI
2026-09-11
The reference study identifies hepatocyte Arrb2 as an upstream regulator of the metabolite 6-ketoLCA, linking hepatocyte stress responses to M2 macrophage polarization during hepatic ischemia–reperfusion injury. Its combination of clinical samples, hepatocyte-focused mouse models, hypoxia–reoxygenation systems, and metabolomics provides a mechanistic framework for studying immune–metabolic control of liver graft injury.
-
Collagen VI ECM Scaffolds Mature iPSC Islet Organoids
2026-09-11
Zhu and colleagues show that decellularized amniotic membrane ECM supports the viability, maturation, endocrine function, and engraftment of iPSC-derived islet organoids. Their analysis identifies collagen VI as a key niche component and provides a biomimetic scaffold strategy for improving organoid transplantation research.
-
Cycloheximide Workflows for Protein Turnover
2026-09-10
Cycloheximide provides a fast way to pause eukaryotic translation and distinguish protein synthesis from protein stability. This practical guide connects dose-finding, apoptosis assay design, and protein turnover measurements to the WWP2–DDX3X mechanism reported in diabetic endothelial injury.
-
Trametinib as a MEK-ERK Pathway Probe
2026-09-10
Trametinib (GSK1120212) provides a precise way to interrogate MEK-ERK signaling beyond conventional oncology assays. This article explains how its use as a pathway-intervention probe can clarify BH4 oxidation, H2O2, and ERK1/2 activation in sensory-neuron research while preserving rigorous assay boundaries.
-
α-Bungarotoxin: Nicotinic Receptor Blockade
2026-09-09
α-Bungarotoxin is a selective α7 nicotinic acetylcholine receptor antagonist used for nicotinic receptor blockade in neuroscience research and cholinergic signaling studies. In a rat placental ischemia model, α-bungarotoxin eliminated pyridostigmine-associated effects, supporting α7 nAChR dependence without establishing clinical efficacy.
-
Morin Workflows for Podocyte Energy Studies
2026-09-09
Morin combines a mechanistic role in podocyte mitochondrial research with fluorescent chelation for aluminum assays. This guide converts those properties into practical preparation, treatment, readout, and troubleshooting workflows while separating published evidence from proposed optimization steps.
-
Cediranib (AZD2171): Measure Response, Not Just Viability
2026-09-08
Cediranib (AZD2171) is a potent VEGFR-pathway probe for dissecting angiogenesis and cancer-cell responses. This article presents a response-measurement framework that separates signaling inhibition, proliferative arrest, and cell death for more informative in vitro experiments.
-
EGCG-Loaded 3D-Printed Bone Scaffolds: Study Insights
2026-09-08
The reference study integrates (-)-Epigallocatechin gallate (EGCG) with binder-jet 3D-printed tricalcium phosphate scaffolds to combine localized release with bone-regeneration, vascularization, anti-osteoclastogenic, and tumor-cell viability effects. Its in vitro results support a multifunctional scaffold concept for low-load craniofacial defects, while also showing why release kinetics and assay-specific interpretation are essential.